Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 2/20 | 0.58 |
| ▸ | CDK2 | P24941 | 2/20 | 0.58 |
| ▸ | PLK1 | P53350 | 2/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.58 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.58 |
| ▸ | PLK2 | Q9NYY3 | 2/20 | 0.58 |
| ▸ | PIM1 | P11309 | 2/20 | 0.56 |
| ▸ | TTK | P33981 | 2/20 | 0.56 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.56 |
| ▸ | ALK | Q9UM73 | 6/20 | 0.51 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.49 |
| ▸ | MAP3K7 | O43318 | 2/20 | 0.49 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | KIT | P10721 | 1/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.49 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.49 |
| ▸ | FLT4 | P35916 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11027974 | 0.83 | SLC2A1 (0.54) | CCNA2CDK2CCNA1PIM1TTK | |
| SCHEMBL11027989 | 0.80 | CCNT1 (0.53) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL11029792 | 0.80 | CCNA2 (0.50) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL11026445 | 0.79 | EGFR (0.51) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL11033146 | 0.77 | ALK (0.58) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL28968032 | 0.75 | MAPK10 (0.49) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL10127381 | 0.74 | ALK (0.64) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL12698419 | 0.72 | TTK (1.00) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL526773 | 0.72 | PLK1 (0.76) | CCNA2CDK2PLK1CCNA1PLK3 | |
| SCHEMBL443851 | 0.72 | IRAK4 (0.50) | CCNA2CDK2PLK1CCNA1PLK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859546-B2 | Picolinamide inhibitors of kinases | ABBVIE INC. (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2665711-A1 | PICOLINAMIDE INHIBITORS OF KINASES | Abbvie Inc. (US) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012100135-A1 | PICOLINAMIDE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2012-07-26 | — | — | WO | disclosed |
| US-20120190681-A1 | PICOLINAMIDE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190681-A1 | PICOLINAMIDE INHIBITORS OF KINASES | ALK, PKN2, ERBB2 | CCNA2 403/4885CDK2 18/4885PLK1 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.